A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : PEA / phosphoethanolamine

[Related PubMed/MEDLINE]
Total Number of Papers: 118
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   PEA  (>> Co-occurring Abbreviation)
Long Form:   phosphoethanolamine
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Beyond electrostatic interactions: Ligand shell modulated uptake of bis-conjugated iron oxide nanoparticles by cells. DOPA, glyc, SPIONs
2020 Clinical Significance of Hypophosphatasemia in Children. HPP, PLP, SALP
2020 Hypophosphatasia: Biological and Clinical Aspects, Avenues for Therapy. ALP, HPP, PLP, TNSALP
2020 Structural characterization of human O-phosphoethanolamine phospho-lyase. ---
2019 Comprehensive proteomic and metabolomic profiling of mcr-1-mediated colistin resistance in Escherichia coli. CAMP, DEPs, LPS
2019 How To Build a Bone: PHOSPHO1, Biomineralization, and Beyond. PCho
2019 Loss of Phosphoethanolamine N-Methyltransferases Abolishes Phosphatidylcholine Synthesis and Is Lethal. PC, PE, PEAMTs
2019 Structural and mechanistic insights into polymyxin resistance mediated by EptC originating from Escherichia coli. E. coli, ITC, LPS
2018 An Evolutionarily Conserved Mechanism for Intrinsic and Transferable Polymyxin Resistance. PE, TM
10  2018 Comparative analysis of phosphoethanolamine transferases involved in polymyxin resistance across 10 clinically relevant Gram-negative bacteria. ---
11  2018 Decorated Superparamagnetic Iron Oxide Nanoparticles with Monoclonal Antibody and Diethylene-Triamine-Pentaacetic Acid Labeled with Thechnetium-99m and Galium-68 for Breast Cancer Imaging. ---
12  2018 Defining ICR-Mo, an intrinsic colistin resistance determinant from Moraxella osloensis. PE, ROS
13  2018 Fluorescent ZnS Quantum Dots-Phosphoethanolamine Nanoconjugates for Bioimaging Live Cells in Cancer Research. HD, QDs
14  2018 Mechanistic insights into transferable polymyxin resistance among gut bacteria. PE
15  2018 Phosphoethanolamine induces caspase-independent cell death by reducing the expression of C-RAF and inhibits tumor growth in human melanoma model. ---
16  2018 Plasma metabolome analysis of patients with major depressive disorder. AUC, MDD
17  2018 Pyridoxal 5'-phosphate and related metabolites in hypophosphatasia: Effects of enzyme replacement therapy. ALP, ERT, HPP, PA, PL, PLP
18  2018 Structure-Function Relationships of the Neisserial EptA Enzyme Responsible for Phosphoethanolamine Decoration of Lipid A: Rationale for Drug Targeting. LPS
19  2018 Substrate analog interaction with MCR-1 offers insight into the rising threat of the plasmid-mediated transferable colistin resistance. ETA
20  2017 A reliable protocol for colorimetric determination of iron oxide nanoparticle uptake by cells. FA, SPIONs
21  2017 Conformational changes in the di-domain structure of Arabidopsis phosphoethanolamine methyltransferase leads to active-site formation. pCho, PMT
22  2017 Deciphering MCR-2 Colistin Resistance. LPS, MALDI-TOF MS
23  2017 Direct demonstration of lipid phosphorylation in the lipid bilayer of the biomimetic bicontinuous cubic phase using the confined enzyme lipid A phosphoethanolamine transferase. DOPE, EptA, MO
24  2017 Hypophosphatasia: An overview For 2017. ALP, HPP, PLP, TNSALP
25  2017 Mutational and biochemical findings in adults with persistent hypophosphatasemia. ALP, HPP, LB, LP, PLP, VUS
26  2017 Thermoresponsive hydrogels based on a phosphorylated star-shaped copolymer: mimicking the extracellular matrix for in situ bone repair. ATRP
27  2016 A phosphoethanolamine transferase specific for the 4'-phosphate residue of Cronobacter sakazakii lipid A. CAMP
28  2015 Bio-nanoplatforms based on carbon dots conjugating with F-substituted nano-hydroxyapatite for cellular imaging. CDs, MTT
29  2015 Clinical Forms and Animal Models of Hypophosphatasia. AP, HPP, Pi, PLP, TNAP
30  2015 Kinetic characterization of the human O-phosphoethanolamine phospho-lyase reveals unconventional features of this specialized pyridoxal phosphate-dependent lyase. PLP
31  2015 Molecular Genetics of Hypophosphatasia and Phenotype-Genotype Correlations. HPP, PLP, TNAP
32  2015 Phosphoethanolamine Modification of Neisseria gonorrhoeae Lipid A Reduces Autophagy Flux in Macrophages. LOS
33  2015 Phosphoethanolamine Transferase LptA in Haemophilus ducreyi Modifies Lipid A and Contributes to Human Defensin Resistance In Vitro. APs, LOS, Sap
34  2014 An alternative mechanism for the methylation of phosphoethanolamine catalyzed by Plasmodium falciparum phosphoethanolamine methyltransferase. QM/MM
35  2014 Low-toxic Mn-doped ZnSe@ZnS quantum dots conjugated with nano-hydroxyapatite for cell imaging. ---
36  2014 Phase-variable expression of lptA modulates the resistance of Neisseria gonorrhoeae to cationic antimicrobial peptides. CAMPs
37  2014 Phosphoethanolamine decoration of Neisseria gonorrhoeae lipid A plays a dual immunostimulatory and protective role during experimental genital tract infection. CAMPs, LOS, TLR4
38  2014 Solid-phase covalent immobilization of upconverting nanoparticles for biosensing by luminescence resonance energy transfer. ESEM, LRET, QDs, UCNPs
39  2014 The role of oxidoreductases in determining the function of the neisserial lipid A phosphoethanolamine transferase required for resistance to polymyxin. LOS
40  2013 A Case of Vitamin D Deficiency without Elevation of Serum Alkaline Phosphatase in a Carrier of Hypophosphatasia. ALP
41  2013 Clinical spectrum of hypophosphatasia diagnosed in adults. AP, HPP, PLP
42  2013 Lipid A's structure mediates Neisseria gonorrhoeae fitness during experimental infection of mice and men. ---
43  2013 Phosphoethanolamine residues on the lipid A moiety of Neisseria gonorrhoeae lipooligosaccharide modulate binding of complement inhibitors and resistance to complement killing. C4BP, FH, LOS, NHS, PorB
44  2013 The structure of the neisserial lipooligosaccharide phosphoethanolamine transferase A (LptA) required for resistance to polymyxin. LptA
45  2013 Thermoresponsive hydrogels from phosphorylated ABA triblock copolymers: a potential scaffold for bone tissue engineering. ATRP, SBF
46  2013 [Phosphoethanolamine in the brain of the eurythermal pond fish Perccottus glehni (Eleotridae, Perciformes, Dyb. 1877) as a phenomenon depending on temperature factor]. FAA
47  2012 CdSe and ZnSe quantum dots capped with PEA for screening C-reactive protein in human serum. CRP, QDs
48  2012 Structure and reaction mechanism of phosphoethanolamine methyltransferase from the malaria parasite Plasmodium falciparum: an antiparasitic drug target. AdoMet, PfPMT
49  2011 Chemiluminescence detection of label-free C-reactive protein based on catalytic activity of gold nanoparticles. CL, CRP, ELISA, GNPs
50  2011 Lipooligosaccharide Structure is an Important Determinant in the Resistance of Neisseria Gonorrhoeae to Antimicrobial Agents of Innate Host Defense. LOS, NHS
51  2011 Understanding non-enzymatic aminophospholipid glycation and its inhibition. Polar head features affect the kinetics of Schiff base formation. APP, PLP, PSer
52  2010 Common sialylated glycan in Actinobacillus suis. ---
53  2010 Identification of phosphomethylethanolamine N-methyltransferase from Arabidopsis and its role in choline and phospholipid metabolism. PCho, PMEAMT
54  2010 Lack of sustained response to teriparatide in a patient with adult hypophosphatasia. ALP, HPP, PLP, TNSALP
55  2010 Molecular switching fluorescence based high sensitive detection of label-free C-reactive protein on biochip. CRP, GPTS, MSF
56  2010 Selective detection and estimation of C-reactive protein in serum using surface-functionalized gold nano-particles. CRP, GNP
57  2009 Glycosylation differences contribute to distinct catalytic properties among bone alkaline phosphatase isoforms. BALP, PLP, pNPP, TNALP
58  2009 Profiles of structural heterogeneity in native lipooligosaccharides of Neisseria and cytokine induction. LA, LOS, LPS, TLR4, TOF, TREM
59  2009 The fine structure of Neisseria meningitidis lipooligosaccharide from the M986 strain and three of its variants. LOS
60  2008 Modification of lipooligosaccharide with phosphoethanolamine by LptA in Neisseria meningitidis enhances meningococcal adhesion to human endothelial and epithelial cells. LOS
61  2008 Structural requirements for monoclonal antibody 2-1-L8 recognition of neisserial lipooligosaccharides. LOS, mAbs
62  2007 ATP-mediated mineralization of MC3T3-E1 osteoblast cultures. beta-GP, PLP, PMCA1, TG2
63  2007 Functional involvement of PHOSPHO1 in matrix vesicle-mediated skeletal mineralization. MV
64  2007 Hypophosphatasia. ALPL, AP, TNAP
65  2007 Peptide design and structural characterization of a GPCR loop mimetic. GPCRs, S1P, TM
66  2007 Use of chemically modified thermoresponsive copolymers for the detection of C-reactive protein. CRP, NIPAAm-GMA
67  2006 Biochemical analysis of Lpt3, a protein responsible for phosphoethanolamine addition to lipooligosaccharide of pathogenic Neisseria. HepII, LOS, mAb
68  2006 O-Acetylation of the terminal N-acetylglucosamine of the lipooligosaccharide inner core in Neisseria meningitidis. Influence on inner core structure and assembly. LOS
69  2006 Separation and identification of neisserial lipooligosaccharide oligosaccharides using high-performance anion-exchange chromatography with pulsed amperometric detection. HPAE-PAD, LOS, OS
70  2005 Cationic antimicrobial peptide resistance in Neisseria meningitidis. CAMPs, PxB
71  2005 Halomonas campaniensis sp. nov., a haloalkaliphilic bacterium isolated from a mineral pool of Campania Region, Italy. DPG, PG
72  2005 Inner core assembly and structure of the lipooligosaccharide of Neisseria meningitidis: capacity of strain NMB to express all known immunotype epitopes. LOS
73  2004 Human PHOSPHO1 exhibits high specific phosphoethanolamine and phosphocholine phosphatase activities. HAD, PCho
74  2004 The MisR/MisS two-component regulatory system influences inner core structure and immunotype of lipooligosaccharide in Neisseria meningitidis. LOS
75  2003 Neisserial lipooligosaccharide is a target for complement component C4b. Inner core phosphoethanolamine residues define C4b linkage specificity. 6-PEA, Hep I, LOS
76  2002 In vivo monitoring of amino acids by direct sampling of brain extracellular fluid at ultralow flow rates and capillary electrophoresis. Asp, ECF, GABA, Glu, Gly, PDC
77  2002 Molecular and biochemical characterization of a cold-regulated phosphoethanolamine N-methyltransferase from wheat. MT
78  2001 Identification of new aqueous chemical degradation products of isophosphoramide mustard. bisAzIPM, CEA-HCl, IPM, monoAzIPM, monoOHIPM, Pi
79  2001 The structure of the lipooligosaccharide (LOS) from the alpha-1,2-N-acetyl glucosamine transferase (rfaK(NMB)) mutant strain CMK1 of Neisseria meningitidis: implications for LOS inner core assembly and LOS-based vaccines. Hep, LOS, OS
80  2000 Neutrophil alkaline phosphatase (NAP) score in the diagnosis of hypophosphatasia. NAP, PLP, TNSALP
81  1999 Characterization of the mineral in calcified articular cartilagenous tissue formed in vitro. ATP, beta-GP
82  1999 Neisseria gonorrhoeae that infect men have lipooligosaccharides with terminal N-acetyllactosamine repeats. LOS, mAbs
83  1999 The structural heterogeneity of the lipooligosaccharide (LOS) expressed by pathogenic non-typeable Haemophilus influenzae strain NTHi 9274. FAB-MS, HF, LOS, MALDITOF-MS, NMR, NTHi, OS
84  1998 Channelling of intermediates in the biosynthesis of phosphatidylcholine and phosphatidylethanolamine in mammalian cells. P-choline, PC, PE
85  1998 Coupling on-line brain microdialysis, precolumn derivatization and capillary electrophoresis for routine minute sampling of O-phosphoethanolamine and excitatory amino acids. CE-LIFD, EAAs
86  1998 The lipooligosaccharide (LOS) of Neisseria meningitidis serogroup B strain NMB contains L2, L3, and novel oligosaccharides, and lacks the lipid-A 4'-phosphate substituent. HepI, LOS, OS
87  1998 [Different sensitivity biochemical mechanisms to mycobacterium tuberculosis of guinea pigs and rats]. EA, ET, MT
88  1997 Absolute concentrations of metabolites in human brain tumors using in vitro proton magnetic resonance spectroscopy. ---
89  1997 Structure of the variable and conserved lipopolysaccharide oligosaccharide epitopes expressed by Haemophilus influenzae serotype b strain Eagan. LPS, OS
90  1995 Alkaline phosphatase: placental and tissue-nonspecific isoenzymes hydrolyze phosphoethanolamine, inorganic pyrophosphate, and pyridoxal 5'-phosphate. Substrate accumulation in carriers of hypophosphatasia corrects during pregnancy. ALP, PLP
91  1995 Effects of vagus nerve stimulation on amino acids and other metabolites in the CSF of patients with partial seizures. CSF, EA, VNS
92  1994 Phosphorylethanolamine content of human brain tumors. ---
93  1993 Clinical and laboratory studies of severe periodontal disease in an adolescent associated with hypophosphatasia. A case report. ALP, ELISA
94  1991 Elevation of taurine in hippocampal extracellular fluid and cerebrospinal fluid of acutely hypoosmotic rats: contribution by influx from blood? EA
95  1991 Minimal oligosaccharide structures required for induction of immune responses against meningococcal immunotype L1, L2, and L3,7,9 lipopolysaccharides determined by using synthetic oligosaccharide-protein conjugates. ELISA, IgG, LPS
96  1991 The influence of the adjuvant Quil A on the epitope specificity of meningococcal lipopolysaccharide anti-carbohydrate antibodies. ---
97  1991 [A case of severe periodontal disease in adolescence associated with hypophosphatasia]. ALP, ELISA
98  1991 [Phosphoethanolamine in the blood and urine in sick children]. ---
99  1990 Alkaline phosphatase (tissue-nonspecific isoenzyme) is a phosphoethanolamine and pyridoxal-5'-phosphate ectophosphatase: normal and hypophosphatasia fibroblast study. 4-MUP, ALP, PI-PLC, PLP, TNS
100  1990 In vivo substitution of choline for sodium evokes a selective osmoinsensitive increase of extracellular taurine in the rat hippocampus. ---